A clinical formulation indicated for Neurology. This medication facilitates acute relief by narrowing specific intracranial blood vessels associated with sensory disturbance and head pain.
A triptan medication developed to alleviate acute migraine pain and associated symptoms like nausea and intended to support rapid recovery from attacks.
Mechanism of Action
It stimulates specific serotonin receptors in the brain, causing constricted blood vessels and reducing inflammatory chemicals that contribute to migraine pain and sensitivity.
Route of Administration
Oral
Onset Time
30–60 minutes
Duration
Up to 24 hours
Contraindications
Ischemic heart disease, Uncontrolled hypertension, History of stroke, Allergy to rizatriptan
Severe Adverse Events
Heart attack, Serotonin syndrome, Severe cardiovascular events, Stroke
Information for Maxalt is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
